Evodiamine prevents traumatic brain injury through inhibiting oxidative stress via PGK1/NRF2 pathway

Taken together, we demonstrated that Evo improved the outcomes after TBI by targeting the PGK1/NRF2 signaling-regulated oxidative stress. Evo may represent a potential therapy to promote recovery from TBI.